Insight: How Novo Nordisk misread the US market for its weight loss sensation – Reuters

1. Insight: How Novo Nordisk misread the US market for its weight loss sensation  Reuters
2. Novo Nordisk shares fall as obesity pipeline faces investor scrutiny  Reuters
3. Henderson European says Novo Nordisk hurts asset value ahead of merger  Morningstar
4. Powerful new weight-loss drug helps patients shed 20 percent of body weight, study finds  University of Alabama at Birmingham
5. Diabetes Dialogue: REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD  HCPLive

Continue Reading